Antiplatelet therapy - Part II

S. H. Goodnight, Bruce M Coull, J. H. McAnulty, L. M. Taylor

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We summarize current information about aspirin and other antiplatelet drugs in patients with cardiac and vascular disease. For each indication, we briefly summarize the rationale for the use of antiplatelet therapy and describe the findings of relevant clinical trials. We propose recommendations for the use of these agents in clinical practice. In Part 2, we discuss the use of antiplatelet agents in coronary angioplasty, atrial fibrillation, artificial cardiac valves, stroke, and peripheral vascular disease. In Part 1, we reviewed the use of antiplatelet therapy for the primary and secondary prevention of myocardial infarction, in conjunction with coronary thrombolysis, in patients with unstable and chronic stable angina, and following coronary artery-saphenous vein bypass grafting.

Original languageEnglish (US)
Pages (from-to)506-514
Number of pages9
JournalWestern Journal of Medicine
Volume158
Issue number5
StatePublished - 1993
Externally publishedYes

Fingerprint

Platelet Aggregation Inhibitors
Stable Angina
Peripheral Vascular Diseases
Heart Valves
Saphenous Vein
Primary Prevention
Secondary Prevention
Vascular Diseases
Angioplasty
Atrial Fibrillation
Aspirin
Heart Diseases
Coronary Vessels
Stroke
Myocardial Infarction
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Goodnight, S. H., Coull, B. M., McAnulty, J. H., & Taylor, L. M. (1993). Antiplatelet therapy - Part II. Western Journal of Medicine, 158(5), 506-514.

Antiplatelet therapy - Part II. / Goodnight, S. H.; Coull, Bruce M; McAnulty, J. H.; Taylor, L. M.

In: Western Journal of Medicine, Vol. 158, No. 5, 1993, p. 506-514.

Research output: Contribution to journalArticle

Goodnight, SH, Coull, BM, McAnulty, JH & Taylor, LM 1993, 'Antiplatelet therapy - Part II', Western Journal of Medicine, vol. 158, no. 5, pp. 506-514.
Goodnight SH, Coull BM, McAnulty JH, Taylor LM. Antiplatelet therapy - Part II. Western Journal of Medicine. 1993;158(5):506-514.
Goodnight, S. H. ; Coull, Bruce M ; McAnulty, J. H. ; Taylor, L. M. / Antiplatelet therapy - Part II. In: Western Journal of Medicine. 1993 ; Vol. 158, No. 5. pp. 506-514.
@article{57a8c4eea23f41a19448391362b858b9,
title = "Antiplatelet therapy - Part II",
abstract = "We summarize current information about aspirin and other antiplatelet drugs in patients with cardiac and vascular disease. For each indication, we briefly summarize the rationale for the use of antiplatelet therapy and describe the findings of relevant clinical trials. We propose recommendations for the use of these agents in clinical practice. In Part 2, we discuss the use of antiplatelet agents in coronary angioplasty, atrial fibrillation, artificial cardiac valves, stroke, and peripheral vascular disease. In Part 1, we reviewed the use of antiplatelet therapy for the primary and secondary prevention of myocardial infarction, in conjunction with coronary thrombolysis, in patients with unstable and chronic stable angina, and following coronary artery-saphenous vein bypass grafting.",
author = "Goodnight, {S. H.} and Coull, {Bruce M} and McAnulty, {J. H.} and Taylor, {L. M.}",
year = "1993",
language = "English (US)",
volume = "158",
pages = "506--514",
journal = "Western Journal of Medicine",
issn = "0093-0415",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - Antiplatelet therapy - Part II

AU - Goodnight, S. H.

AU - Coull, Bruce M

AU - McAnulty, J. H.

AU - Taylor, L. M.

PY - 1993

Y1 - 1993

N2 - We summarize current information about aspirin and other antiplatelet drugs in patients with cardiac and vascular disease. For each indication, we briefly summarize the rationale for the use of antiplatelet therapy and describe the findings of relevant clinical trials. We propose recommendations for the use of these agents in clinical practice. In Part 2, we discuss the use of antiplatelet agents in coronary angioplasty, atrial fibrillation, artificial cardiac valves, stroke, and peripheral vascular disease. In Part 1, we reviewed the use of antiplatelet therapy for the primary and secondary prevention of myocardial infarction, in conjunction with coronary thrombolysis, in patients with unstable and chronic stable angina, and following coronary artery-saphenous vein bypass grafting.

AB - We summarize current information about aspirin and other antiplatelet drugs in patients with cardiac and vascular disease. For each indication, we briefly summarize the rationale for the use of antiplatelet therapy and describe the findings of relevant clinical trials. We propose recommendations for the use of these agents in clinical practice. In Part 2, we discuss the use of antiplatelet agents in coronary angioplasty, atrial fibrillation, artificial cardiac valves, stroke, and peripheral vascular disease. In Part 1, we reviewed the use of antiplatelet therapy for the primary and secondary prevention of myocardial infarction, in conjunction with coronary thrombolysis, in patients with unstable and chronic stable angina, and following coronary artery-saphenous vein bypass grafting.

UR - http://www.scopus.com/inward/record.url?scp=0027263134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027263134&partnerID=8YFLogxK

M3 - Article

VL - 158

SP - 506

EP - 514

JO - Western Journal of Medicine

JF - Western Journal of Medicine

SN - 0093-0415

IS - 5

ER -